MULTISYSTEM IN CHILDREN ASSOCIATED WITH SARS-COV-2 INFLAMMATORY SYNDROME

Abstract

The pandemic associated with severe acute respiratory syndrome coronavirus infection 2 (SARS-CoV-2) has a steady prevalence and registration of new cases and deaths worldwide. A special category of patients is represented by severe pediatric patients with multisystem inflammatory syndrome (MBS) associated with SARS-CoV-2, which, apparently, is an analogue of the severe course of COVID-19 in adults and occurs with damage to several organs. In particular, children have fever, rash, conjunctivitis, peripheral edema of the palms and feet, gastrointestinal disorders, respiratory, cardiovascular, kidney damage, and lymphadenopathy.
The authors set out to study the clinical and laboratory manifestations of AIM in children associated with SARS-CoV-2 on the experience of the Department of General Pediatrics of JSC "Scientific Center of Pediatrics and Pediatric Surgery" of the Ministry of Health of the Republic of Kazakhstan.